Show simple item record

dc.contributor.authorRashed, A
dc.contributor.authorPuvaneswaralingam, S
dc.contributor.authorMcBain, Catherine A
dc.contributor.authorHigham, Claire E
dc.date.accessioned2019-01-10T13:02:06Z
dc.date.available2019-01-10T13:02:06Z
dc.date.issued2018en
dc.identifier.citationRashed A, Puvaneswaralingam S, McBain CA, Higham CE. Assessing the prevalence of glucocorticoid prescription and other fracture risk factors in a prospective unselected neuro-oncology patient population to inform a policy for bone health management. Osteoporosis Int. 2018;29:641.en
dc.identifier.urihttp://hdl.handle.net/10541/621468
dc.language.isoenen
dc.titleAssessing the prevalence of glucocorticoid prescription and other fracture risk factors in a prospective unselected neuro-oncology patient population to inform a policy for bone health management.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentEndocrinology, Christie Hospital, Manchester, UKen
dc.identifier.journalOsteoporosis Internationalen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record